1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Lotus Eye Hospital And Institute Ltd

Lotus Eye Hospital And Institute Ltd

112.40
INR
+1.63
(+1.47%)
0.07EPS
1,586.63P/E
2.43BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
13.8
14.38
14.97
15.86
16.96
18.16
19.23
15.23
18.31
22.11
22.72
23.37
25.23
28.24
Basic EPS, GAAP
0.02
-0.95
0.05
0.21
0.84
0.34
0.51
0.75
1.44
1.96
1.4
0.36
0.04
0.07
Free Cash Flow per Basic Share
-0.44
-1.5
1.07
0.72
0.72
-0.24
1.23
1.08
-0.13
0.62
0.02
-1.02
-4.82
- -
Dividend per Share
- -
- -
- -
- -
0.6
0.6
- -
- -
0.5
0.5
0.49
0.01
0.01
- -
Book Value per Share
24.7
23.75
23.8
24.07
24.35
24.1
24.65
25.34
26.26
27.69
28.57
28.85
28.92
- -
Tangible Book Value per Share
24.66
23.72
23.59
23.97
24.24
24
24.54
25.26
26.2
27.64
28.53
28.79
28.81
- -
Basic Weighted Avg Shares
21
21
21
21
21
21
21
21
21
21
21
21
21
20
Sales/Revenue/Turnover
287
299
311
335
353
378
400
317
381
460
472
486
525
573
Operating Margin (%)
-0.57
-6.1
-1.33
0.73
3.92
1.12
4.42
4.16
9.1
10.25
6.15
1.14
-0.37
0.5
Depreciation Expense
35
47
44
34
34
31
25
23
25
30
37
30
37
46
Net Income, GAAP
- -
-20
1
4
17
7
11
16
30
41
29
7
1
1
Effective Tax Rate (%)
60.92
- -
- -
- -
- -
- -
26.86
21.29
27.09
27.86
27.39
46.53
- -
34.17
Profit Margin (%)
0.14
-6.63
0.32
1.32
4.95
1.87
2.66
4.95
7.84
8.87
6.17
1.52
0.15
0.26
Working Capital
-1
-11
10
26
11
10
47
78
71
95
77
41
20
- -
LT Debt
- -
7
5
3
1
1
4
1
7
2
7
20
130
- -
Total Equity
514
494
495
501
506
501
513
527
546
576
594
600
601
- -
Return on Invested Capital (%)
-0.13
- -
- -
- -
- -
- -
1.44
2.1
4.6
5.98
3.57
0.49
- -
- -
Return on Capital (%)
0.08
- -
- -
- -
- -
- -
2.16
3.07
5.65
7.27
5.03
1.5
- -
- -
Return on Common Equity (%)
0.08
-3.93
0.2
0.89
3.47
1.41
2.1
3.02
5.56
7.27
4.98
1.24
0.13
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
28
- -
LT Borrowings
- -
102
- -
LT Finance Leases
- -
28
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
21
21
21
Market Capitalization
2,480
2,043
2,429

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
114
- -
Cash, Cash Equivalents & STI
- -
37
- -
Accounts Receivable, Net
- -
12
- -
Inventories
- -
38
- -
Total Current Liabilities
- -
93
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
28
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.98%
2.69%
0.23%
Free Cash Flow
-658.22%
-1,158.07%
371.16%
Net Income, GAAP
60.68%
-13.06%
-89.12%
Sales/Revenue/Turnover
5.96%
10.92%
7.97%
Total Cash Common Dividend
- -
- -
9.35%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
129
129
122
115
486
2026
135
130
135
136
525
2027
171
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.3
0.05
-0.11
0.12
0.36
2026
0.26
0.06
-0.13
-0.15
0.04
2027
0.3
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.01
2026
- -
- -
- -
- -
0.01
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
S. K. Sundaramoorthy
Full Time Employees
402
Sector
Health services
Industry
Medical/Nursing services
Address
SF No. 770/12, Avinashi Road Coimbatore TN India 641014
IPO Date
Jun 12, 2008
Website
lotuseye.org
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Mobile-health Network Solutions (NASDAQ:MNDR)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) operates as a specialty eye care provider offering comprehensive ophthalmology services, including cataract surgery, glaucoma treatment, retinal disorders management, corneal transplants, oculoplasty, pediatric ophthalmology, and refractive surgery such as LASIK; it also provides diagnostic services like optical coherence tomography, fundus photography, and visual field testing, along with pharmacy and optical dispensing. The company serves patients across urban and rural segments in India, with a network of hospitals and clinics primarily concentrated in southern and eastern regions including Tamil Nadu, Andhra Pradesh, Telangana, and West Bengal. Founded in 1999 and headquartered in Coimbatore, India, Lotus Eye maintains a focus on affordable, high-volume eye care delivery through its super-specialty facilities and community outreach programs. In recent developments, the company expanded its capacity with the launch of a new super-specialty eye hospital in Bhubaneshwar in 2023 and reported robust financial growth in fiscal year 2025, driven by increased surgical volumes and strategic investments in advanced equipment; it also strengthened its market position through tie-ups with insurance providers for broader accessibility.